Zobrazeno 1 - 10
of 84
pro vyhledávání: '"STEVEN R. BAUER"'
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 5, Pp n/a-n/a (2024)
Abstract Background Previously, we discovered that human solid tumours, but not normal human tissues, preferentially overexpress interleukin‐13Receptor alpha2, a high binding receptor for IL‐13. To develop novel anti‐cancer approaches, we const
Externí odkaz:
https://doaj.org/article/3ec837ceb5c14fce9430dd4a6f1980ce
Autor:
Pamela Leland, Dhiraj Kumar, Sridhar Nimmagadda, Steven R. Bauer, Raj K. Puri, Bharat H. Joshi
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Chimeric antigen receptor (CAR) T cell therapy is an exciting cell-based cancer immunotherapy. Unfortunately, CAR-T cell therapy is associated with serious toxicities such as cytokine release syndrome (CRS) and neurotoxicity. The
Externí odkaz:
https://doaj.org/article/1bc89e7fdbc84ef3bc6abeaa5d5f5630
Autor:
Pamela Leland, Dhiraj Kumar, Sridhar Nimmagadda, Steven R. Bauer, Raj K. Puri, Bharat H. Joshi
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/466dae3f5f0847caa40d6ed25ccb56cb
Autor:
Alicia D. Henn, Taci Pereira, Joshua Hunsberger, Kunal Mitra, Zohreh Izadifar, Sita Somara, Lisa Lindström, Thomas Forest Farb-Horch, Jake Boy, George F. Muschler, Steven R. Bauer, Randy Yerden
Publikováno v:
Frontiers in Medical Technology, Vol 5 (2023)
Any Regenerative Medicine (RM) business requires reliably predictable cell and tissue products. Regulatory agencies expect control and documentation. However, laboratory tissue production is currently not predictable or well-controlled. Before condit
Externí odkaz:
https://doaj.org/article/73933c98d9224efc94e8307ff2aca00b
Autor:
Andrew M. Lewis, Gideon Foseh, Wei Tu, Keith Peden, Adovi Akue, Mark KuKuruga, Daniel Rotroff, Gladys Lewis, Ilya Mazo, Steven R. Bauer
Publikováno v:
PLoS ONE, Vol 18, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/cc95f0ed93794b67b546fdb2fc0e62ca
Publikováno v:
Stem Cells Translational Medicine, Vol 7, Iss 9, Pp 664-675 (2018)
Abstract Multipotent stromal cells (MSCs) are an attractive cell source for bone and cartilage tissue repair strategies. However, the functional heterogeneity of MSCs derived from different donors and manufacturing conditions has limited clinical tra
Externí odkaz:
https://doaj.org/article/14b646e71e2e4f4faea395c48c1f830b
Publikováno v:
Data in Brief, Vol 5, Iss C, Pp 864-870 (2015)
Bone-marrow derived mesenchymal stromal cells (BMSCs) have been in clinical trials for therapy. One major bottleneck in the advancement of BMSC-based products is the challenge associated with cell isolation, characterization, and ensuring cell fitnes
Externí odkaz:
https://doaj.org/article/0cf89519734d43d58ab8041eac0c9291
Publikováno v:
Stem Cell Research, Vol 15, Iss 3, Pp 655-664 (2015)
Human bone marrow stromal cells (hBMSCs, also loosely called bone marrow-derived mesenchymal stem cells) are the subject of increasing numbers of clinical trials and laboratory research. Our group recently reported on the optimization of a workflow f
Externí odkaz:
https://doaj.org/article/89cb7a2613994869b4746d2c5a6029dc
Autor:
Bahar Mirshekar-Syahkal, Esther Haak, Gillian M. Kimber, Kevin van Leusden, Kirsty Harvey, John O'Rourke, Jorge Laborda, Steven R. Bauer, Marella F. T. R. de Bruijn, Anne C. Ferguson-Smith, Elaine Dzierzak, Katrin Ottersbach
Publikováno v:
Haematologica, Vol 98, Iss 2 (2013)
The first mouse adult-repopulating hematopoietic stem cells emerge in the aorta-gonad-mesonephros region at embryonic day (E) 10.5. Their numbers in this region increase thereafter and begin to decline at E12.5, thus pointing to the possible existenc
Externí odkaz:
https://doaj.org/article/0e2e28f91c7d4a36b92c84d783536705
3D bioprinting optimization of human mesenchymal stromal cell laden gelatin-alginate-collagen bioink
Autor:
Stephen W Sawyer, Kazuyo Takeda, Alaadin Alayoubi, Eman Mirdamadi, Ahmed Zidan, Steven R Bauer, Heba Degheidy
Publikováno v:
Biomedical materials (Bristol, England). 18(1)
3D bioprinting technology has gained increased attention in the regenerative medicine and tissue engineering communities over the past decade with their attempts to create functional living tissues and organs de novo. While tissues such as skin, bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e70beb80f21c502d20adf02554a8f71
https://pubmed.ncbi.nlm.nih.gov/36395510
https://pubmed.ncbi.nlm.nih.gov/36395510